Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Cell Cycle (Georgetown, Tex.)|September 25, 2007
p53 reactivation kills KSHV lymphomas efficiently in vitro and in vivo: new hope for treating aggressive viral lymphomasGrzegorz Sarek, Päivi M OjalaBlood|September 15, 2005
KSHV viral cyclin inactivates p27KIP1 through Ser10 and Thr187 phosphorylation in proliferating primary effusion lymphomasGrzegorz Sarek, Annika Järviluoma, Päivi M OjalaTrends in Cell Biology|March 4, 2014
RTEL1: functions of a disease-associated helicaseJean-Baptiste Vannier, Grzegorz Sarek, Simon J BoultonNature Structural & Molecular Biology|November 20, 2015
Molecular basis of telomere dysfunction in human genetic diseasesGrzegorz Sarek, Paulina Marzec, Pol Margalef, et al.Journal of Virology|March 23, 2012
Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with multifunctional angiogenin to utilize its antiapoptotic functionsNitika Paudel, Sathish Sadagopan, Sayan Chakraborty, et al.Molecular Cell|January 27, 2015
TRF2 recruits RTEL1 to telomeres in S phase to promote t-loop unwindingGrzegorz Sarek, Jean-Baptiste Vannier, Stephanie Panier, et al.The Journal of Clinical Investigation|March 17, 2007
Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomasGrzegorz Sarek, Sari Kurki, Juulia Enbäck, et al.Molecular and Cellular Biology|March 2, 2006
Phosphorylation of the cyclin-dependent kinase inhibitor p21Cip1 on serine 130 is essential for viral cyclin-mediated bypass of a p21Cip1-imposed G1 arrestAnnika Järviluoma, Emma S Child, Grzegorz Sarek, et al.Plos Pathogens|March 25, 2010
Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latencyGrzegorz Sarek, Annika Järviluoma, Henna M Moore, et al.Molecular Cell|January 21, 2018
A Distinct Class of Genome Rearrangements Driven by Heterologous RecombinationAna María León-Ortiz, Stephanie Panier, Grzegorz Sarek, et al.Pageof 2